Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan Finn currently holds 11,666 shares of ATOSSA THERAPEUTICS, INC. (ATOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Finn has been a net buyer of ATOS stock. They have purchased $44.3K and sold $0 worth of shares.
Jonathan Finn's most recent insider trade was on May 12, 2026, when they sold 10,000 shares at $0.00 per share.
Jonathan Finn serves as Executive at ATOSSA THERAPEUTICS, INC. (ATOS). They have executed 9 insider transactions totaling $44.3K over their tenure at the company.
Jonathan Finn holds the position of Executive at ATOSSA THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Jonathan Finn has shown a buying trading pattern, with $44.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jonathan Finn was on Apr 10, 2024, when they purchased $44.3K worth of ATOS shares. This transaction involved 25,000 shares at $1.77 per share.
Jonathan Finn currently owns 11,666 shares of ATOSSA THERAPEUTICS, INC. (ATOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan Finn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan Finn has 9 Form 4 filings on record as an insider at ATOSSA THERAPEUTICS, INC..
Set alerts for Jonathan Finn and 40,000+ other insiders.